Lin-Rahardja K, Scarborough JA, Scott JG
Personalizing chemotherapy drug selection using a novel transcriptomic chemogram
PLOS Computational Biology
Preprint: https://www.biorxiv.org/content/10.1101/2024.12.17.628754v1
|
|
Ho, E., De Cecco, L., Eschrich, S. A., Cavalieri, S., Sedor, G., Hoebers, F. J., ... & Scott, J. G.
Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation dose
The Journal of Clinical Investigation
Preprint: https://www.medrxiv.org/content/10.1101/2023.09.14.23295538v1
|
|
Card KJ, Crozier D, Durmaz A, Gray J, Creary J, Stocks A, Maltas J, Bonomo RA, Burke ZDC, Scott JG
Evolution under vancomycin selection drives divergent collateral sensitivity patterns in Staphylococcus aureus
PNAS
Preprint: https://www.biorxiv.org/content/10.1101/2023.11.30.569373v3
|
|
Vargas, R., Petty, A., Lindner, D. J., Parker, Y., Yard, B., Durmaz, A., ... & Scott, J
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer
npj Precision Oncology
Preprint: https://www.biorxiv.org/content/10.1101/2022.09.06.505009v3
|
|
King ES, Pelesko J, Maltas J, Owen SJ, Dolson E, Scott JG
Fitness seascapes are necessary for realistic modeling of the evolutionary response to drug therapy.
Science Advances
Preprint: https://www.biorxiv.org/content/10.1101/2022.06.10.495696.abstract
|
|
Nosrat, F., Dede, C., McCullum, L. B., Garcia, R., Mohamed, A. S. R., Scott, J. G., Bates, J. E., McDonald, B. A., Wahid, K. A., Naser, M. A., He, R., Karagoz, A., Moreno, A. C., van Dijk, L. V., Brock, K. K., Heukelom, J., Hosseinian, S., Hemmati, M., Schaefer, A. J., & Fuller, C. D.
Optimal timing of organs-at-risk-sparing adaptive radiation therapy for head-and-neck cancer under re-planning resource constraints.
Physics and Imaging in Radiation Oncology
|
|
Scarborough, J., Weaver, D., & Scott, J. G.
Gene signatures and oncology treatment implications.
Hematology/Oncology Clinics
|
|
Dinh, M. N., Hitomi, M., Al-Turaihi, Z. A., & Scott, J. G.
Alamar Blue assay optimization to minimize drug interference and inter-assay viability.
MethodsX
|
|
Wei, R., Hitomi, M., Sadler, T., Yehia, L., Calvetti, D., Scott, J. G., & Eng, C.
Quantitative evaluation of DNA damage repair dynamics to elucidate predictors of autism vs. cancer in individuals with germline PTEN variants.
PLOS Computational Biology
|
|
Mayo, Z. S., Fan, C., Jia, X., Parker, S. M., Kocsis, J., Shah, C. S., Scott, J. G., & Campbell, S. R.
Meta-analysis of 5-fraction preoperative radiotherapy for soft tissue sarcoma.
American Journal of Clinical Oncology
|
|
Shultes, P. V., Weaver, D. T., Tadele, D. S., Barker-Clarke, R. J., & Scott, J. G.
Cell-cell fusion in cancer: The next cancer hallmark?
The International Journal of Biochemistry & Cell Biology
|
|
15. Wang, M., Scott, J. G., & Vladimirsky, A.
Threshold-awareness in adaptive cancer therapy
PLOS Computational Biology
|
|
Naghavi, A. O., Bryant, J. M., Kim, Y., Weygand, J., Redler, G., Sim, A. J., Miller, J., Coucoules, K., Michael, L. T., Gloria, W. E., Yang, G., Rosenberg, S. A., Ahmed, K., Bui, M. M., Henderson-Jackson, E. B., Lee, A., Lee, C. D., Gonzalez, R. J., Feygelman, V., Eschrich, S. A., Scott, J. G., Torres-Roca, J., Latifi, K., Parikh, N., & Costello, J.
Habitat escalated adaptive therapy (HEAT): A phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma
BMC Cancer
|
|
Maltas J, Tadele DS, Durmaz A, McFarland CD, Hinczewski M, Scott JG
Frequency-dependent ecological interactions increase the prevalence and shape the distribution of pre-existing drug resistance
PRX Life
Preprint: https://www.biorxiv.org/content/10.1101/2023.03.16.533001v1
|
|
King ES, Tadele DS, Pierce B, Hinczewski M, Scott JG
Diverse mutant selection windows shape spatial heterogeneity in evolving populations
PLOS Computational Biology
Preprint: https://www.biorxiv.org/content/10.1101/2023.03.09.531899v3
|
|
Weaver DT, Maltas J, Scott JG
Reinforcement Learning informs optimal treatment strategies to limit antibiotic resistance
PNAS
Preprint: https://www.biorxiv.org/content/10.1101/2023.01.12.523765v1
|
|
Cho YB, Yoon N, Suh JH, Scott JG
Radio-immune response modelling for spatially fractionated radiotherapy
Physics in Medicine & Biology
|
|
Torres-Roca JF, Grass D, Scott JG, Eschrich S
Towards Data Driven RT Prescription: Integrating Genomics into RT Clinical Practice
Seminars in Radiation Oncology
|
|
Barker-Clarke R, Weaver DT, Scott JG
Graph 'texture' features as novel metrics that can summarize complex biological graphs
Physics in Medicine & Biology
Preprint: https://www.biorxiv.org/content/10.1101/2022.11.21.517417v2
|
|
Somasundaram E, Wadhwa RR, Litzler A, Barker-Clarke R, Qi P, Videtic G, Stephans K, Pennell NA, Raymond D, Yang K, Kattan MW, Scott JG
Clinical Nomogram Using Novel Computed Tomography–Based Radiomics Predicts Survival in Patients With Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy
JCO Clinical Cancer Informatics
Preprint: https://www.medrxiv.org/content/10.1101/2022.06.21.22276718v1
|
|
Kewan T, Durmaz A, Bahaj W, Gurnari C, Terkawi L, Awada H, Ogbue OD, Ahmed R, Pagliuca S, Awada H, Kutoba Y. Minako M, Povilawan B, Al-Share B, Patel B, Carraway H, Scott JG, Balasubramanian S, Bat T, Madanat Y, Sekeres M, Haferlach T, Visconte V, Maciejewski J
Molecular patterns identify distinct subclasses of myeloid neoplasia
Nature Communications
|
|
Scarborough JA, Eschrich SA, Torres-Roca J, Dhawan A, Scott JG
Exploiting convergent evolution to derive a pan-cancer cisplatin sensitivity gene expression signature
NPJ Precision Oncology
Preprint: https://www.medrxiv.org/content/10.1101/2021.11.10.21265799v1
|
|
Lin-Rahardja K, Weaver DT, Scarborough JA, Scott JG
Evolution-Informed Strategies for Combating Drug Resistance in Cancer
International Journal of Molecular Sciences
|
|
Scarborough JA and Scott JG.
Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology
Seminars in Radiation Oncology
|
|
Weaver DT, Pishas KI, Williamson D, Scarborough JA, Lessnick SL, Dhawan A and Scott JG.
Network potential identifies therapeutic miRNA cocktails in Ewings Sarcoma
Plos Computational Biology
Preprint: https://www.biorxiv.org/content/10.1101/854695v1
|
|
Yoon N, Krishnan N, Scott JG.
Modeling of collaterally sensitive drug cycles, and optimization of the drug effect in the spirit of adaptive therapy
Journal of Mathematical Biology
Preprint: https://www.biorxiv.org/content/10.1101/2020.07.02.184952v1
|
|
Somasundaram E, Litzler A, Wadhwa RR, Scott JG.
Persistent Homology of Tumor CT Scans Predicts Survival In Lung Cancer
Medical Physics
Preprint: https://www.medrxiv.org/content/10.1101/2020.12.06.20244863v1
|
|
Scott JG, Sedor G, Ellsworth P, Scarborough JA, Ahmed K, Oliver DE, Eschrich SA, Kattan MW, Torres-Roca JF.
GARD is a pan-cancer predictor of clinical outcome in radiation treated patients
Lancet Oncology
Preprint: https://www.medrxiv.org/content/10.1101/2020.12.19.20248484v1
|
|
Scarborough JA, Tom MC, Kattan MW, Scott JG.
Revisiting a null hypothesis: Exploring the parameters of oligometastasis treatment
International Journal of Radiation Oncology*Biology*Physics
Preprint: https://www.medrxiv.org/content/10.1101/2020.08.10.20172098v1
|
|
Parsai S, Qiu RLJ, Qi P, Sedor G, Fuller CD, Murray E, Majkszak D, Dorio N, Koyfman S, Woody N, Joshi N, Scott JG.
In vivo assessment of the safety of standard fractionation temporally feathered radiation therapy (TFRT) for head and neck squamous cell carcinoma: An R-IDEAL stage I/2a first-in-humans/feasibility demonstration of new technology implementation
Radiotherapy and Oncology
Preprint: https://www.medrxiv.org/content/10.1101/2021.01.05.21249232v1
|
|
Weaver DT, McElvany BD, Gopalakrishnan V, Card KJ, Crozier D, Dhawan A, Dinh MN, Dolson E, Farrokhian N, Hitomi M, Ho E, Jagdish T, King ES, Cadnum JL, Donskey CJ, Krishnan N, Kuzmin G, Li J, Maltas J, Mo J, Pelesko J, Scarborough JA, Sedor G, Tian E, An GC, Diehl SA, Scott JG.
UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic
Plos One
Preprint: https://www.medrxiv.org/content/10.1101/2020.03.25.20043489v2
|
|
Kayani BJ, Weaver DT, Gopalakrishnan V, King ES, Dolson E, Krishnan N, Pelesko J, Scott MJ, Hitomi M, Cadnum JL, Li DF, Donskey CJ, Scott JG, Charnas I.
UV-C Tower for point-of-care decontamination of filtering facepiece respirators
American Journal of Infection Control
Preprint: https://www.medrxiv.org/content/10.1101/2020.03.25.20043489v2
|
|
Somasundaram EV, Brown SE, Litzler A, Scott JG, Wadhwa RR
Benchmarking R packages for Calculation of Persistent Homology
The R journal
|
|
Awada H, Durmaz A, Gurnari C, Kishtagari A, Meggendorfer M, Kerr CM, Kuzmanovic T, Durrani J, Shreve J, Nagata Y, Radivoyevitch T, Advani AS, Ravandi F, Carraway HE, Nazha A, Haferlach C, Saunthararajah Y, Scott JG, Visconte V, Kantarjian H, Kadia T, Sekeres MA, Haferlach T, Maciejewski JP,
Machine Learning Integrates Genomic Signatures for Subclassification beyond Primary and Secondary Acute Myeloid Leukemia
Blood
|
|
Parsai S, Qui RLJ, Qi P, Alfonso JCL, Donaghue J, Murray E, Majkszak D, Dorio N, Fuller CD, Brock K, Koyfman S, Woody N, Joshi N, Scott JG.
Technical Note: A step-by-step guide to temporally feathered radiation therapy planning for head and neck cancer
Journal of Applied Clinical Medical Physics
|
|
Scott JG, Sedor G, Kattan MW, Peacock J, Grass GD, Mellon EA, Thapa R, Schell M, Waller A, Poppen S, Andl G, Eschrich SA, Dilling TJ, Dalton WS, Harrison LB, Fox T Torres-Roca JF.
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Preprint: https://www.medrxiv.org/content/10.1101/2020.01.09.20017046v2
|
|
Nagata Y, Zhao R, Awada H, Kerr CM, Mirzaev I, Kongkiatkamon S, Nazha A, Makishima H, Radivoyevitch T, Scott JG, Sekeres MA, Hobbs BP, Maciejewski JP.
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic features
Blood
|
|
Grimes DR, Jansen M, Macauley RJ, Scott JG, Basanta D.
Evidence for hypoxia increasing the tempo of evolution in glioblastoma
British Journal of Cancer
Preprint: https://www.biorxiv.org/content/10.1101/293712
|
|
Iram S, Dolson E, Chiel J, Pelesko J, Krishnan N, Gungor O, Kuznets-Speck B, Defner S, Ilker E, Scott JG and Hinczewski M.
Controlling the speed and trajectory of evolution with counterdiabatic driving
Nature Physics
Preprint: https://www.biorxiv.org/content/10.1101/867143v1
|
|
Scarborough JA, McClure E, Anderson P, Dhawan A, Durmaz A, Lessnick SL, Hitomi M and Scott JG.
Identifying states of collateral sensitivity during the evolution of therapeutic resistance in Ewing’s sarcoma
iScience
Preprint: https://www.biorxiv.org/content/10.1101/2020.02.11.943936v2
|
|
Parsai S, Lawrenz J, Kilpatrick S, Rubin B, Hymes C, Gray M, Mesko N, Shah C, Nystrom L and Scott JG.
Early Outcomes of Preoperative 5-fraction Radiation Therapy for Soft Tissue Sarcoma Followed by Immediate Surgical Resection
Advances in Radiation Oncology
Preprint: https://www.medrxiv.org/content/10.1101/2020.03.20.20038885v1.full
|
|
Vander Velde R, Yoon N, Marusyk V, Dhawan A, Balynska O, Desai B, Peral D, Myroshnychenko D, Poleszhuk J, Liu K, Mian O, Abazeed M, Haura E, Scott JG and Marusyk A.
Resistance to ALK targeting therapies as a gradual Darwinian adaptation to inhibitor specific selective pressures.
Nature Communications
Preprint: https://www.biorxiv.org/content/10.1101/504837v2
|
|
Gluzman M, Scott JG and Vladimirski A.
Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory.
Proceedings of the Royal Society, B
Preprint: https://www.biorxiv.org/content/10.1101/491829v1.full
|
|
Scott JG, Maini PK, Anderson ARA and Fletcher AG.
Inferring Tumour Proliferative Organisation from Phylogenetic Tree Measures in a Computational Model.
Systematic Biology
Preprint: https://www.biorxiv.org/content/10.1101/334946v2
|
|
Ahmed KA, Liveringhouse CL, Mills MN, Figura NB, Grass GD, Washington IR, Harris EE, Czerniecki BJ, Blumencranz PW, Eschrich SA, Scott JG, Diaza R, Torres-Roca JF.
Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.
EBioMedicine
Preprint: https://www.biorxiv.org/content/10.1101/334946v2
|
|
Rockne R, Hawkins-Daarud A, Swanson KR, Sluka JP, Glazier JA, Macklin P, Hormuth D, Jarrett AM, Fonseca Lima EAB, Oden J, Birosa G, Yankeelov TE, Curtius K, Al Bakir I, Wodarz D, Komarova N, Aparicio L, Bordyuh M, Rabadan R, Finley S, Enderling H, Caudell JJ, Moros EG, Anderson ARA, Gatenby R, Kaznatcheev A, Jeavons P, Krishnan N, Pelesko J, Wadhwa R, Yoon N, Nichol D, Marusyk A, Hinczewski M and Scott JG,
The 2019 Mathematical Oncology Roadmap.
Physical Biology
|
|
Dhawan A, Barberis A, Cheng WC, Domingo E, West C, Maughan T, Scott JG, Harris AL and Buffa FM,
Guidelines for using sigQC for systematic evaluation of gene signatures.
Nature Protocols
|
|
Kaznatcheev A, Peacock J, Basanta D, Marusyk A and Scott JG.,
Fibroblasts and alectinib switch the evolutionary games that non-small cell lung cancer plays.
Nature Ecology and Evolution
Preprint: https://www.biorxiv.org/content/early/2018/08/07/179259
|
|
Nichol D, Rutter J, Bryant C, Hujer AM, Lek S, Adams MD, Jeavons P, Anderson ARA, Bonomo RA and Scott JG.
Antibiotic collateral sensitivity is contingent on the repeatability of evolution.
Nature Communications
Preprint: https://www.biorxiv.org/content/10.1101/185892v4
|
|
Scott JG, Dhawan A, Hjelmeland A, Lathia J, Chumakova A, Hitomi M, Fletcher AG, Maini PK and Anderson ARA,
Recasting the cancer stem cell hypothesis: unification using a continuum model of microenvironmental forces.
Current Stem Cell Reports
Preprint: https://www.biorxiv.org/content/10.1101/169615v2
|
|
Dhawan A, Scott JG, Harris AL and Buffa FM.
Pan-cancer characterisation of microRNA with hallmarks of cancer reveals role of microRNA-mediated downregulation of tumour suppressor genes.
Nature Communications
Preprint: https://www.biorxiv.org/content/10.1101/238675v2
|
|
Dhawan A, Harris AL, Buffa FM and Scott JG.
Endogenous miRNA sponges mediate the generation of oscillatory dynamics for a non-coding RNA network.
Journal of Theoretical Biology
Preprint: https://www.biorxiv.org/content/early/2018/03/31/292029
|
|
Wadhwa RR, Williamson DFK, Dhawan A and Scott JG.
TDAstats: R pipeline for computing persistent homology in topological data analysis.
Journal of Open Source Software
|
|
Mirzaev I, Williamson DFK and Scott JG.
egtplot: A python package for three strategy evolutionary games.
Journal of Open Source Software
Preprint: https://www.biorxiv.org/content/10.1101/300004v2
|
|
Vargas R, Gopal C, Kuzmishin GB, DeBernardo R, Koyfman SA, Jha BK, Mian OY, Scott JG, Adams DJ, Peacock CD and Abazeed ME.
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response.
npj Precision Oncology
|
|
Nichol D, Bonomo RA and Scott JG.
It's too soon to pull the plug on antibiotic cycling.
The Lancet Infectious Disease
|
|
Curtis GL, Lawrenz JM, George J, Styron JF, Scott J, Shah C, Shepard DR, Rubin B, Nystrom LM and Mesko NW.
Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database.
Journal of Surgical Oncology
|
|
Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, Schwartz R, Kim S, Rosenstein BS.
Machine Learning and Radiogenomics: Lessons Learned and Future Directions.
Frontiers in Oncology
|
|
Alfonso JCL, Parsai S, Joshi N, Godley A, Koyfman SA, Caudell JJ, Fuller CD, Enderling H and Scott JG.
Temporally-Feathered Intensity Modulated Radiation Therapy: A technique to reduce normal tissue toxicity.
Medical Physics
Preprint: https://www.biorxiv.org/content/early/2017/09/03/184044
|
|
Yoon N, Vander Velde R, Marusyk A and Scott JG.
Optimal Therapy Scheduling Based on a Pair of Collaterally Sensitive Drugs.
Bulletin of Mathematical Biology
Preprint: https://www.biorxiv.org/content/early/2017/10/13/196824
|
|
Ahmed KA, Scott JG, Arrington JA, Naghavi AO, Grass GD, Perez BA, Caudell JJ, Berglund AE, Welsh EA, Eschrich SA, Dilling TJ and Torres-Roca JF.
Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose.
Journal of Thoracic Oncology
|
|
Ottino-Loffler B, Scott JG, and Strogatz SH.
Evolutionary dynamics of incubation periods.
eLife
Preprint: https://www.biorxiv.org/content/10.1101/144139v1
|
|
Zhou M, Scott JG, Chaudhury B, Hall L, Goldgof D, Yeom KW, Iv M, Ou Y, Kalpathy-Cramer J, Napel S and Gillies R.
Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches.
American Journal of Neuroradiology
|
|
Karthik N, Ward MC, Scott JG, Mesko N and Shah CS.
Factors Associated With Acute and Chronic Wound Complications in Patients With Soft-Tissue Sarcoma With Long-Term Follow-Up.
American Journal of Clinical Oncology
|
|
Naghavi AO, Gonzalez RJ, Scott JG, Abuodeh YA, Echevarria M, Mullinax JE, Ahmed KA, Harrison LB and Fernandez DC.
Staged Reconstruction Brachytherapy Has Lower Overall Cost in Recurrent Soft Tissue Sarcoma.
Practical Radiation Oncology
|
|
Naghavi AO, Fernandez DC, Mesko N, Juloori A, Martinez A, Scott JG, Shah C and Harrison LB.
American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy.
Brachytherapy
|
|
Ottino-Löffler B, Scott JG, and Strogatz SH.
Takeover times for a simple model of network infection.
Physical Review E
|
|
Scott JG and Marusyk A.
Somatic clonal evolution: A selection-centric perspective.
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer
|
|
Kaznatcheev A, Vander Velde R, Scott JG and Basanta D.
Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature.
British Journal of Cancer
Preprint: https://www.biorxiv.org/content/10.1101/067488v1
|
|
Naghavi AO, Gonzalez RJ, Scott JG, Kim Y, Abuodeh YA, Strom TJ, Echevarria M, Mullinax JE, Ahmed KA, Harrison LB and Fernandez DC.
Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma.
Journal of contemporary brachytherapy
|
|
McFarland CD, Yaglom JA, Wojtkowiak JW, Scott JG, Morse DL, Sherman MY and Mirny L.
The damaging effect of passenger mutations on cancer progression.
Cancer Research
|
|
Grassberger C, Scott JG and Paganetti H.
Biomathematical Optimization of Radiation Therapy in the Era of Targeted Agents.
International Journal of Radiation Oncology*Biology*Physics
|
|
Dhawan A, Nichol D, Kinose F, Abazeed ME, Marusyk A, Haura EB and Scott JG.
Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer.
Scientific Reports
|
|
Perni S, Mohamed AS, Scott JG, Enderling H, Garden AS, Gunn GB, Rosenthal DI and Fuller CD.
CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy.
Oral oncology
|
|
Farhidzadeh H, Goldgof DB, Hall LO, Scott JG, Gatenby RA, Gillies RJ and Raghavan M.
A quantitative histogram-based approach to predict treatment outcome for Soft Tissue Sarcomas using pre-and post-treatment MRIs.
2016 IEEE International Conference on Systems, Man, and Cybernetics
|
|
Rietman, EA, Scott JG, Tuszynski JA and Klement GL.
Personalized anticancer therapy selection using molecular landscape topology and thermodynamics.
Oncotarget
|
|
Naghavi AO, Gonzalez RJ, Scott JG, Mullinax JE, Abuodeh YA, Kim Y, Binitie O, Ahmed KA, Bui MM, Saini AS, and Zager JS and Fernandez DC.
Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma.
Brachytherapy
|
|
Werner B, Scott JG, Sottoriva A, Anderson ARA, Traulsen A and Altrock PM.
The cancer stem cell fraction in hierarchically organized tumors can be estimated using mathematical modeling and patient-specific treatment trajectories.
Cancer Research
|
|
Farhidzadeh H, Kim JY, Scott JG, Goldgof DB, Hall LO and Harrison LB.
Classification of progression free survival with nasopharyngeal carcinoma tumors.
Proceedings of the SPIE, Medical Imaging
|
|
Farhidzadeh H, Chaudhury B, Scott JG, Goldgof DB, Hall LO, Gatenby RA, Gillies RJ and Raghavan M.
Signal intensity analysis of ecological defined habitat in soft tissue sarcomas to predict metastasis development.
Proceedings of the SPIE, Medical Imaging
|
|
Scott JG, Fletcher AG, Anderson ARA and Maini PK.
Spatial metrics of tumour vascular organisation predict radiation efficacy in a computational model.
PLoS Computational Biology
|
|
Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS and Mellon E and Torres-Roca JT.
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
The Lancet Oncology
|
|
Scott JG, Kuhn P and Anderson ARA.
Unifying metastasis—integrating intravasation, circulation and end-organ colonization.
Nature Reviews Cancer
|
|
Scott JG, Bauchet L, Fraum TJ, Nayak L, Cooper AR, Chao ST, Suh JH, Vogelbaum MA, Peereboom DM, Zouaoui S, Mathieu‐Daudé H and Iwamoto F.
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older.
Cancer
|
|
Finkelstein SE, Rodriguez F, Dunn M, Farmello M-J, Smilee R, Janssen W, Kang L, Chuang T, Seigne J, Pow-Sang J, Torres-Roca JF, Heysek R, Biagoli M, Shankar R, Scott JG, Antonia S, Gabrilovich D, Fishman M.
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy.
Immunotherapy
|
|
Scott JG.
Phase i trialist.
The Lancet Oncology
|
|
Basanta D, Scott JG, Fishman MN, Ayala G, Hayward SW and Anderson ARA.
Investigating prostate cancer tumour–stroma interactions: clinical and biological insights from an evolutionary game.
British Journal of Cancer
|
|
Scott JG, Tsai YY, Chinnaiyan P and Yu HHM.
Effectiveness of radiotherapy for elderly patients with glioblastoma.
International Journal of Radiation Oncology*Biology*Physics
|
|
Scott JG, Suh JH, Elson P, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GHJ, Elinzano H, Chao ST.
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases.
Neuro Oncology
|
|